The NB-hop classifier significantly stratified patients with tumor stage 1, 2, 3, and 4, patients with age < 18 months, patients with age > 18 months, and patients with not amplified MYCN tumor (p < 0.05). The gene discussed is MYCN; the disease is neoplasm.